Legal Representation
Attorney
Duane M. Byers
USPTO Deadlines
Application History
18 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Feb 28, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Feb 28, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Feb 28, 2025 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
Dec 24, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Dec 23, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Dec 23, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Dec 10, 2024 | LIME | X | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | Loading... |
Jul 27, 2024 | LIMG | M | LIMITATION OF GOODS RECEIVED FROM IB | Loading... |
Jul 15, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
Jun 24, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
Jun 24, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
Jun 7, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
Jun 7, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
May 23, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
May 18, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Apr 24, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
Mar 8, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Mar 7, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 035
Outsource service provider in the field of administrative business management
Class 042
Scientific and technological services in the fields of biology, medicine and pharmaceuticals, and research and design relating thereto; industrial analysis and research services in the fields of biology, medicine and pharmaceuticals; design and development of computer hardware and software
Class 044
Medical services; Hygienic and beauty care for human beings
Additional Information
Design Mark
The mark consists of the wording "DEBIOPHARM" above the wording "WE DEVELOP FOR PATIENTS" with all wording in black stylized font to the right of a red circle with a white dot inside.
Color Claim
The color(s) black, red, white is/are claimed as a feature of the mark.
Classification
International Classes
035
042
044